Proud to share our preprint of Henry’s CRISPR-based Oligo Recombineering platform for the prioritization of covalent drug targets - check it out here, and really excited to have that work highlighted by Twist Bioscience here - go Henry!
Proud to share our preprint of Henry’s CRISPR-based Oligo Recombineering platform for the prioritization of covalent drug targets - check it out here, and really excited to have that work highlighted by Twist Bioscience here - go Henry!
